Team Antikor

Antikor has an active, highly experienced and award-winning team of board members and founding scientists, including:-

Antikor Board Members

• Dr Till Medinger : Non-executive Chairman (former Senior Vice President for Corporate Strategy at AstraZeneca Plc, formerly Director at Domantis).
• Dr Mahendra Deonarain : CEO/CSO (Honorary Reader in Antibody Technology and Therapeutics at Imperial College London)
• Dr Elizabeth Rollinson : Non-executive Director (CEO Linnean Society of London, former Commercial Director for the Xenova Group Plc and Managing Director of Phogen)
• Dr Carlos Pittol : Non-executive Director & Chief Business Officer (Director at Clubb Capital Ltd) 

Founding Core Scientific Team* and Science Advisory Board

• Dr Till Medinger : (see above)
• Dr Mahendra Deonarain (*Founder) : CEO/CSO & Technical Director: Biotechnology
  (Honorary Reader in Antibody Technology and Therapeutics at Imperial College London).
• Dr Gokhan Yahioglu (*Founder) : Technical Director: Chemistry
• Dr Lionel Milgrom (*Founder) : (science writer; former Senior Lecturer in Chemistry and Senior Visiting Scientist, Imperial College London).
• Professor David Phillips OBE (*Founder) - Photophysics 
  (President of the Royal Society of Chemistry; Emeritus Professor of Chemistry and former Dean of Sciences, Imperial College London).
• Dr Elizabeth Rollinson : (see above)
• Mr Colin Hopper : consultant
  (Senior Research Fellow,National Medical Laser Centre, London; Head of Oral and Maxillo-Facial Surgery, Eastman Dental Hospital; Consultant Head & Neck Surgeon and Honorary Senior Lecturer, University College London)